SEC Form 4 · accession 0001209191-15-030755
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Reid M Huber
Officer — EVP, Chief Scientific Officer
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2015 | M | 17,499 | $18.32 | A | 61,907 | D | |
| Common Stock | Mar 30, 2015 | M | 16,764 | $17.79 | A | 78,671 | D | |
| Common StockF1,F2,F3 | Mar 30, 2015 | S | 10,000 | $93.67 | D | 68,671 | D | |
| Common StockF1,F2,F4 | Mar 30, 2015 | S | 8,000 | $93.61 | D | 60,671 | D | |
| Common StockF1,F2,F5 | Mar 30, 2015 | S | 7,000 | $93.66 | D | 53,671 | D | |
| Common StockF1,F2,F6 | Mar 30, 2015 | S | 5,000 | $93.67 | D | 48,671 | D | |
| Common StockF1,F2,F7 | Mar 30, 2015 | S | 4,263 | $93.75 | D | 44,408 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F8 | $18.32 | Mar 30, 2015 | M | 17,499 | D | — | Feb 8, 2020 | Common Stock | 17,499 | 21,709 | D |
| Non-Qualified Stock Option (right to buy)F9 | $17.79 | Mar 30, 2015 | M | 16,764 | D | — | Jan 18, 2019 | Common Stock | 16,764 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F3Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
- F4Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.05.
- F5Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
- F6Represents weighted average sale price. Actual sale prices ranged from $92.78 - $96.00.
- F7Represents weighted average sale price. Actual sale prices ranged from $92.67 - $96.00.
- F8Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F9Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.